The estimated Net Worth of Jennifer L Taubert is at least $32.7 Million dollars as of 13 February 2024. Ms. Taubert owns over 1,302 units of Johnson & Johnson stock worth over $25,632,312 and over the last 6 years she sold JNJ stock worth over $0. In addition, she makes $7,097,300 as Executive Vice President - Worldwide Chairman and Pharmaceuticals at Johnson & Johnson.
Jennifer has made over 11 trades of the Johnson & Johnson stock since 2019, according to the Form 4 filled with the SEC. Most recently she exercised 1,302 units of JNJ stock worth $214,596 on 13 February 2024.
The largest trade she's ever made was exercising 76,923 units of Johnson & Johnson stock on 22 November 2022 worth over $5,579,994. On average, Jennifer trades about 13,126 units every 83 days since 2019. As of 13 February 2024 she still owns at least 155,517 units of Johnson & Johnson stock.
You can see the complete history of Ms. Taubert stock trades at the bottom of the page.
Jennifer L. Taubert serves as Executive Vice President - Worldwide Chairman, Pharmaceuticals of the Company. She joined the Company in 2005 as Worldwide Vice President at Johnson & Johnson Pharmaceutical Services, a subsidiary of the Company. She held several executive positions of increasing responsibility in the Pharmaceutical sector until 2012 when she was appointed Company Group Chairman, North America Pharmaceuticals, and in 2015 became Company Group Chairman, The Americas, Pharmaceuticals. In July 2018, Ms. Taubert was promoted to Executive Vice President, Worldwide Chairman, Pharmaceuticals, and became a member of the Executive Committee. Ms. Taubert has responsibility for the Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism, and Pulmonary Hypertension businesses throughout Janssen.
As the Executive Vice President - Worldwide Chairman and Pharmaceuticals of Johnson & Johnson, the total compensation of Jennifer Taubert at Johnson & Johnson is $7,097,300. There are 4 executives at Johnson & Johnson getting paid more, with Alex Gorsky having the highest compensation of $25,365,800.
Jennifer Taubert is 56, she's been the Executive Vice President - Worldwide Chairman and Pharmaceuticals of Johnson & Johnson since 2018. There are 22 older and 8 younger executives at Johnson & Johnson. The oldest executive at Johnson & Johnson is Ronald Williams, 70, who is the Independent Director.
Jennifer's mailing address filed with the SEC is MCDONALD'S CORPORATION, 110 NORTH CARPENTER STREET, CHICAGO, IL, 60607.
Over the last 21 years, insiders at Johnson & Johnson have traded over $59,929,946 worth of Johnson & Johnson stock and bought 21,998 units worth $2,578,685 . The most active insiders traders include Hubert Joly, Anne M Mulcahy, and Alex Gorsky. On average, Johnson & Johnson executives and independent directors trade stock every 21 days with the average trade being worth of $4,572,436. The most recent stock trade was executed by Robert J Decker on 30 August 2024, trading 5,635 units of JNJ stock currently worth $563,838.
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Johnson & Johnson executives and other stock owners filed with the SEC include: